Skip to content
Subscriber Only

NHS Data Miner Could Be Worth $291 Million After Share Sale

A company aiming to use patient data from the U.K.’s National Health Service’s to help pharma companies develop new drugs is getting ready to sell shares in London.

Paul Drayson, who has served as U.K. science minister, is preparing an initial public offering of Sensyne Health, which analyzes anonymous data from hospitals to help develop treatments, devices and clinical apps. The company has applied for listing on the London Stock Exchange’s AIM market for smaller companies beginning Aug. 17, said Drayson, Sensyne’s chief executive officer.